Polyphor launches the development of an inhaled antibiotic murepavadin
Polyphor Ltd has announced €5m funding, in order to support and accelerate the development of an inhaled dosage form of murepavadin...
List view / Grid view
Polyphor Ltd has announced €5m funding, in order to support and accelerate the development of an inhaled dosage form of murepavadin...
FDA-approved drug holds promise for first effective treatment to prevent trauma-induced heterotopic ossification formation...
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
New study shows ALK inhibitor ceritinib may have the ability to be used for more than ALK-rearranged non-small cell lung cancer...
The French National Agency for Medicines and Health Products Safety is set to launch a Phase I/II clinical trial for HORA-PDE6B, in the treatment of a retinitis pigmentosa...
Widely available ibuprofen is a better choice for pain relief in children who have undergone minor surgery, as it has fewer adverse effects compared with oral morphine...
Researchers have combined low-intensity electric current with a formulation containing nano-encapsulated chemotherapy to treat skin cancer...
Researchers have discovered evidence that stomach acid suppression alters specific gut bacteria in a way that promotes liver injury and progression of three types of chronic liver disease...
As part of EPR’s Women in Pharma series, Lori Reilly, Executive Vice President, Policy, Research & Membership, talks to Science Editor Dr Zara Kassam about the importance of having strong female mentors...
Researchers have identified that stroke patients with dementia treated with IVT, using clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients...
The FDA has granted Breakthrough Therapy Designation for Tagrisso for the 1st-line treatment of patients with NSCLC...
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
NICE has issued a final appraisal determination recommending that venclyxto is made available to patients with chronic lymphocytic leukaemia...
Researchers have collaborated to design a smart bandage that could eventually heal chronic wounds...
Researchers have developed a technology - that can quickly identify potential drug combinations to control parasitic worms...